Edition:
United States

Kissei Pharmaceutical Co Ltd (4547.T)

4547.T on Tokyo Stock Exchange

2,693JPY
26 Sep 2016
Change (% chg)

¥9 (+0.34%)
Prev Close
¥2,684
Open
¥2,694
Day's High
¥2,714
Day's Low
¥2,688
Volume
86,500
Avg. Vol
135,998
52-wk High
¥3,245
52-wk Low
¥1,915

Latest Key Developments (Source: Significant Developments)

Kyorin and KISSEI sign agreement for co-development and co-marketing of KRP-114V
Wednesday, 30 Mar 2016 02:00am EDT 

Kyorin Holdings Inc:KYORIN Pharmaceutical Co., Ltd., a wholly-owned subsidiary of KYORIN Holdings, Inc. and Kissei Pharmaceutical Co., Ltd. jointly announced a co-development and co-marketing agreement for an overactive bladder medication of KRP-114V (INN: Vibegron) which is being developed by Kyorin in Japan.  Full Article

KISSEI PHARMACEUTICAL to retire treasury shares
Friday, 24 Apr 2015 02:00am EDT 

KISSEI PHARMACEUTICAL CO LTD:To retire 2,600,000 shares (4.57 pct stake) of its common stock on May 15.Says the total shares outstanding will be 54,311,185 shares after the retirement.  Full Article

R&I affirms KISSEI PHARMACEUTICAL's rating at "A-" and announces stable outlook
Tuesday, 27 Jan 2015 01:00am EST 

KISSEI PHARMACEUTICAL CO LTD:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-".Rating outlook stable.  Full Article

KISSEI PHARMACEUTICAL CO LTD completes share repurchase
Sunday, 16 Nov 2014 08:00pm EST 

KISSEI PHARMACEUTICAL CO LTD:Repurchased 2,541,700 shares at 7,904,687,000 yen in total on Nov. 17.  Full Article

KISSEI PHARMACEUTICAL CO LTD to repurchase shares
Friday, 14 Nov 2014 02:10am EST 

KISSEI PHARMACEUTICAL CO LTD:Says it will repurchase up to 2,700,000 shares of its common stock, representing a 5.25 pct stake on Nov. 17.Share repurchase price is 3,110 yen per share, the closing price of Nov. 14, or up to 8,397,000,000 yen in total.  Full Article

KISSEI PHARMACEUTICAL CO LTD raises consolidated mid-year outlook for FY 2015
Monday, 27 Oct 2014 03:00am EDT 

KISSEI PHARMACEUTICAL CO LTD:Says the company increased the consolidated mid-year outlook for revenue to 34,610 million yen from 33,800 million yen for FY ending March 2015.Operating profit forecast increased to 5,300 million yen from 4,300 million yen.Ordinary profit forecast increased to 6,430 million yen from 4,800 million yen.Net profit forecast increased to 4,500 million yen from 3,350 million yen.Earnings per share increased to 87.43 yen from 65.09 yen.Comments the gain from revaluation of securities is the main reason for the forecast.  Full Article